Industry involvement

Much of our research is underpinned by collaborations with industry and instrument vendors.

Vendor engagement and collaboration

One-omics and new applications in mass spectrometry in infection and immunity with SCIEX

Precision Immunology with ThermoScientific and Agilent

Industry collaboration

New insights and cures for Psoriasis and Rheumatoid Arthritis with Janssen Pharmaceuticals

Next generation cancer vaccines with Evaxion Biotech

Clinical partners

Our research program is highly focused towards translational medicine in the pursuit of improved clinical outcomes for patients. We are actively engaged in collaborative clinical projects with The Alfred Hospital, Box Hill Hospital, Royal Melbourne Hospital and Monash Medical Centre.

Internationally, we are part of a multidisciplinary medical oncology effort based in Oxford and Southampton in the UK. Tony is a Visiting Professor in Cancer Sciences at the University of Southampton. We are also involved in collaborations with the Center for Drug Safety Science at the University of Liverpool

Selected funding groups

We gratefully acknowledge the funding given to our lab by the following groups:

National Health and Medical research Council (NHMRC) Australia

2023-2027 NHMRC Investigator Grant APP2016596 “An integrated approach to antigen discovery in autoimmunity and cancer” (Purcell)

Medical Research Future Fund (MRFF) Australia

2024-2028 MRFF 2023 NCRI Application NCRI000049 (Davidovich, Schittenhelm, Purcell, Lynn, Shackleton, Rossjohn, Carroll, Filipovska, Bredy, Walkley, Carroll, Snel, Knott, Zhang, Croagh) "RNA Mass Spectrometry Platform"

2024-2028 MRFF 2022 Frontier Health and Medical Research application MRFHMRG000002 (Thomas, March, Rossjohn, Buchbinder, Cope, Isaacs, Wechelakar, Thurecht, Schofield, Purcell,Scherer, Benham, Hansen, Bird, Liew) “RESET RA”

2026-2028 MRFF Early to Mid-Career Researchers Application APP2050465 ( Moonshi, Suwakulsiri, Qureshi, Wong, Small, Tran, Martyn, Giri, Thomas, Nel, Bergot, Braun, Purcell, Wechalekar, Costello) “Translating Antigen-Specific Immunotherapy for Immune Restoration in Psoriatic Arthritis”, A$867,396

Australian Research Council (ARC)

2025-2027 ARC Discovery Project DP250102065 (Rossjohn, Purcell) An investigation into metabolite-mediated immunity

2025-2027 ARC Discovery Project DP250101202 (Le Nours, Purcell) A molecular investigation into marsupial T cell mediated immunity

Other significant grants

2025-2030 CRUK Discovery Research Program Grant DRCPGM-Jun25/100009 (Godkin, Gallimore, MacLachlan, Purcell, Sansom) Optimisation of anti-cancer CD4+ T cell responses through molecularly-informed modification of HLA class II antigens

2026-2027 Tour de Cure Senior Research grant (RSP-217-2026) Harnessing the Plasma Immunopeptidome for Cancer Surveillance and Antigen Discovery (Purcell)